Viewing Study NCT00719550

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:20 PM
Ignite Modification Date: 2026-02-03 @ 12:47 AM
Study NCT ID: NCT00719550
Status: COMPLETED
Last Update Posted: 2013-12-05
First Post: 2008-07-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer
Sponsor: Amgen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Esophagogastric Junction Adenocarcinoma View
None Gastric Cancer View
None Esophageal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Locally Advanced View
None Metastatic View